Stocks With The Highest
Upside Forecast

Based on 25,000+ 1-year price targets provided by
5,000+ Wall Street analysts over the past 3-months

Name Upside % Analysts
bullish %
IOVA icon
1
Iovance Biotherapeutics
IOVA
$807M
707%
upside
3 price targets
0
LRMR icon
2
Larimar Therapeutics
LRMR
$335M
443%
upside
3 price targets
0
CMPX icon
3
Compass Therapeutics
CMPX
$483M
406%
upside
3 price targets
0
ATYR
4
aTyr Pharma
ATYR
$524M
377%
upside
3 price targets
0
CMPS
5
Compass Pathways
CMPS
$461M
360%
upside
3 price targets
0
RGNX icon
6
Regenxbio
RGNX
$455M
292%
upside
4 price targets
0
GPCR icon
7
Structure Therapeutics
GPCR
$1.1B
291%
upside
4 price targets
0
CATX icon
8
Perspective Therapeutics
CATX
$251M
287%
upside
3 price targets
0
KURA icon
9
Kura Oncology
KURA
$700M
271%
upside
3 price targets
0
ALMS
10
Alumis Inc. Common Stock
ALMS
$485M
266%
upside
5 price targets
0
NTLA icon
11
Intellia Therapeutics
NTLA
$1.25B
245%
upside
6 price targets
0
CAN
12
Canaan Creative
CAN
$372M
236%
upside
3 price targets
0
TSHA icon
13
Taysha Gene Therapies
TSHA
$772M
229%
upside
5 price targets
0
CGEM icon
14
Cullinan Oncology
CGEM
$450M
227%
upside
3 price targets
0
BHVN icon
15
Biohaven
BHVN
$1.64B
225%
upside
7 price targets
0
TRVI icon
16
Trevi Therapeutics
TRVI
$878M
212%
upside
5 price targets
0
BCYC
17
Bicycle Therapeutics
BCYC
$491M
212%
upside
4 price targets
0
SENS icon
18
Senseonics Holdings
SENS
$375M
201%
upside
3 price targets
0
VERA icon
19
Vera Therapeutics
VERA
$1.42B
197%
upside
3 price targets
0
TECX
20
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
196%
upside
3 price targets
0
NRIX icon
21
Nurix Therapeutics
NRIX
$719M
191%
upside
5 price targets
0
ATAI icon
22
ATAI Life Sciences
ATAI
$997M
191%
upside
3 price targets
0
SMLR icon
23
Semler Scientific
SMLR
$453M
188%
upside
3 price targets
0
LXEO icon
24
Lexeo Therapeutics
LXEO
$257M
182%
upside
4 price targets
0
EWTX icon
25
Edgewise Therapeutics
EWTX
$1.54B
181%
upside
3 price targets
0